2018
DOI: 10.1016/j.ijsu.2018.03.032
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of topical Dexmedetomidine administration in postlaminectomy epidural fibrosis rat model

Abstract: Epidural fibrosis is a challenging topic in spinal surgery. Numerous clinical and experimental studies have been focused on this issue to clarify problems faced in spinal procedures for the patient as well as the surgeon and find out new methodologies. Dense cytokines and growth factors which are released from inflammatory cells have been suggested to play a major role in the inception and progression of fibrosis. One of the most investigated and important actor in epidural fibrosis is assumed to be the transf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…In our in vivo experiment, the pathological changes in the asthmatic airway, including goblet cell hyperplasia, extracellular matrix deposition, and increased airway smooth muscle mass were mitigated by DEX treatment. The suppressive effect of DEX on fibrosis has been investigated in various tissues and organs [50][51][52]. For example, in an acute kidney injury model, pretreatment with DEX alleviated tubulointerstitial fibrosis and the expression of inflammatory markers via the inhibition of α2-adrenergic receptor and hence hindered the progress of chronic kidney disease [51].…”
Section: Discussionmentioning
confidence: 99%
“…In our in vivo experiment, the pathological changes in the asthmatic airway, including goblet cell hyperplasia, extracellular matrix deposition, and increased airway smooth muscle mass were mitigated by DEX treatment. The suppressive effect of DEX on fibrosis has been investigated in various tissues and organs [50][51][52]. For example, in an acute kidney injury model, pretreatment with DEX alleviated tubulointerstitial fibrosis and the expression of inflammatory markers via the inhibition of α2-adrenergic receptor and hence hindered the progress of chronic kidney disease [51].…”
Section: Discussionmentioning
confidence: 99%
“…Although some studies have suggested the histopathological features of the EF, subsequent studies have rarely reported a better definition of its function. Spine physicians rarely pay attention to EF, and it is mostly linked to epidural fibrosis formation after spinal surgery [17][18][19][20][21][22][23][24][25][26] and clinically uncharacterized back pain [24,27,28]. Recently, novel studies with different views on EF have focused on its regenerative or immunomodulatory function, especially with respect to MSCs derived from EF.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, TGF-1β released from fibroblasts increases the formation of fibrosis by causing a positive feedback on the fibrotic process. [4,9] There are many studies in the literature using a wide range of agents and affecting these molecular steps. Each treatment method used in these studies shows its main effect by affecting different steps of fibrosis formation.…”
Section: Discussionmentioning
confidence: 99%
“…Among the studies regarding the inflammatory response phase, the effect of specific inhibition of inflammatory cytokines and the use of anti-inflammatory agents on epidural fibrosis have been frequently examined in the literature. For the inhibition of specific inflammatory cytokines, etanercept, a TNF-α blocker, [1] tamoxifen, a TGF-β blocker, [7] methyl palmitate, [18] and dexmedetomidine [4] have been extensively investigated. Also, there are studies using diclofenac sodium [20] and curcumin [21] as anti-inflammatory agents.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation